0 results available. Select is focused ,type to refine list, press Down to open the menu,
Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, ...
The following section summarizes insights on Fuji Pharma Co., Ltd.'s Basic EPS Growth:
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Basic EPS Growth in the growth category include:
The basic eps incl extra items growth measures a company’s basic eps incl extra items year-over-year growth. The formula to calculate basic eps growth and an example calculation for Fuji Pharma’s trailing twelve months is outlined below:
Basic EPS Growth = (Current Year - Prior Year) / ABS(Prior Year Basic EPS Incl Extra Items)*
−13.1% = (¥180.9 M - ¥208.2 M) / ¥208.2 M
*ABS = An absolute value adjustment is used to ensure the direction of growth of negative numbers is reflected
The tables below summarizes Fuji Pharma’s performance over the last five years:
| Fiscal Year | Basic EPS Incl Extra Items | Growth |
|---|---|---|
| 2020-09-30 | 66.92 | −31.0% |
| 2021-09-30 | 90.52 | 35.3% |
| 2022-09-30 | 110.98 | 22.6% |
| 2023-09-30 | 141.35 | 27.4% |
| 2024-09-30 | 252.81 | 78.9% |
The tables below summarizes Fuji Pharma’s performance over the last four quarters:
| Quarter Ending | Basic EPS Incl Extra Items | Growth |
|---|---|---|
| 2024-03-31 | 62.44 | 130.6% |
| 2024-06-30 | 26.86 | 210.8% |
| 2024-09-30 | 50.84 | −15.0% |
| 2024-12-31 | 40.74 | −63.8% |
Growth calculations are always made in the company’s reporting currency to ensure currency fluctuations do not impact the calculation. Fuji Pharma’s reports in the JPY currency. You can read more about Basic EPS Incl Extra Items here.